Biotech / Finance

Amgen’s cholesterol drug shows positive effect in cardiovascular outcomes study

From PBR - News
March 20, 2017 - 2:57am
Amgen’s cholesterol drug Repatha (evolocumab) has showed positive effect in a 27,564-patient cardiovascular outcomes study.


Continue reading this article »